Moreover, high ALDH1A2 expression correlates with increased infiltration of anticancer immune cells, suggesting that ALDH1A2 may exert a tumor-suppressive effect in prostate cancer by modulating cell adhesion and anticancer immunity. The gene discussed is ALDH1A2; the disease is prostate carcinoma.